Works matching DE "FORMOTEROL"

Results: 463

Single vs Multiple Inhaler Triple Therapy for COPD Could Triple Adherence, Persistence: International Data.

Published in:

2024

By:

Halsey, Grace

Publication type:

Abstract

AstraZeneca Launches Phase 3 THARROS Trial of Breztri to Reduce Cardiopulmonary Events in COPD.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Formulation and characterization of mometasone furoate and formoterol fumarate containing dry powder inhaler by spray drying and homogenization methods.

Published in:

Journal of Research in Pharmacy, 2022, v. 26, n. 2, p. 383, doi. 10.29228/jrp.136

By:

AKDAG, Yagmur;
GULSUN, Tugba;
IZAT, Nihan;
ONER, Levent;
SAHIN, Selma

Publication type:

Article

A Novel Apparatus for the Determination of Solubility in Pressurized Metered Dose Inhalers.

Published in:

Drug Development & Industrial Pharmacy, 2006, v. 32, n. 10, p. 1159, doi. 10.1080/03639040600920325

By:

Traini, Daniela;
Young, Paul M.;
Price, Robert;
Rogueda, Phillipe

Publication type:

Article

Development of a Lyophilized Formulation for (R,R)-Formoterol (L)-Tartrate.

Published in:

Drug Development & Industrial Pharmacy, 2001, v. 27, n. 1, p. 89, doi. 10.1081/DDC-100000132

By:

Kirsch, Lee;
Zhang, Steven;
Muangsiri, Walaisiri;
Redmon, Martin;
Luner, Paul;
Wurster, Dale

Publication type:

Article

On-Demand ICS + FABA Combinations in 6–11-Year-Old Children.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 23, p. 7270, doi. 10.3390/jcm12237270

By:

Navarrete-Rodríguez, Elsy M.;
Del-Rio-Navarro, Blanca E.;
Larenas-Linnemann, Désirée;
Castro-Rodriguez, Jose A.

Publication type:

Article

Attenuation of Age-Related Muscle Wasting and Weakness in Rats After Formoterol Treatment: Therapeutic Implications for Sarcopenia.

Published in:

Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2007, v. 62, n. 8, p. 813, doi. 10.1093/gerona/62.8.813

By:

Ryall, James G.;
Schertzer, Jonathan D.;
Lynch, Gordon S.

Publication type:

Article

Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial.

Published in:

NPJ Primary Care Respiratory Medicine, 2017, p. 1, doi. 10.1038/s41533-017-0032-z

By:

Pilcher, Janine;
Patel, Mitesh;
Pritchard, Alison;
Thayabaran, Darmiga;
Ebmeier, Stefan;
Shaw, Dominick;
Black, Peter;
Braithwaite, Irene;
Weatherall, Mark;
Beasley, Richard

Publication type:

Article

Use of concomitant inhaled corticosteroids: pooled data from two phase III studies of aclidinium plus formoterol in COPD.

Published in:

NPJ Primary Care Respiratory Medicine, 2017, p. 1, doi. 10.1038/s41533-016-0009-3

By:

D’Urzo, Anthony;
Singh, Dave;
Gil, Esther Garcia

Publication type:

Article

The frequency of, and adherence to, single maintenance and reliever therapy instructions in asthma: a descriptive analysis.

Published in:

NPJ Primary Care Respiratory Medicine, 2016, p. 16038, doi. 10.1038/npjpcrm.2016.38

By:

DiSantostefano, Rachael L;
Boudiaf, Nada;
Stempel, David A;
Barnes, Neil C;
Greening, Andrew P

Publication type:

Article

Single inhaler with beclometasone, formoterol, and glycopyrronium versus triple therapies in adults with uncontrolled asthma: a systematic review and meta-analysis.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-88374-w

By:

Braido, Fulvio;
Vlachaki, Ioanna;
Nikolaidis, Georgios F.;
Tzelis, Dimitrios;
Barouma, Ifigeneia;
Piraino, Alessio;
Madoni, Alessandra;
Scichilone, Nicola

Publication type:

Article

Formoterol induces muscle regeneration through myogenic regulatory factor MyoD in rat model of statin-induced myopathy.

Published in:

2023

By:

Qamar, Abdullah;
Hamid, Shabnam;
Mushtaq, Fareeha;
Abdullah, Muhammad Saad;
Umbreen, Faiza;
Khalid, Rabya

Publication type:

Abstract

Pharmacokinetics of Co‐Suspension Delivery Technology Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate (BGF MDI) and Budesonide/Formoterol Fumarate Dihydrate (BFF MDI) Fixed‐Dose Combinations Compared With an Active Control: A Phase 1, Randomized, Single‐Dose, Crossover Study in Healthy Adults

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 2, p. 223, doi. 10.1002/cpdd.585

By:

Maes, Andrea;
DePetrillo, Paolo;
Siddiqui, Shahid;
Reisner, Colin;
Dorinsky, Paul

Publication type:

Article

Pharmacokinetics of aclidinium bromide/formoterol fumarate fixed-dose combination compared with individual components: A phase 1, open-label, single-dose study.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 2, p. 109, doi. 10.1002/cpdd.209

By:

Fuhr, Rainard;
Leselbaum, Anne;
Aubets, Jordi

Publication type:

Article

An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 3, p. 229, doi. 10.1002/cpdd.97

By:

Kosoglou, Teddy;
Hubbell, James;
Kantesaria, Bhavna;
Hanson, Mary E.;
Cutler, David L.

Publication type:

Article

Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 3, p. 222, doi. 10.1002/cpdd.94

By:

Kosoglou, Teddy;
Hubbell, James;
Johnson‐Levonas, Amy O.;
Yunan, Mona;
Kantesaria, Bhavna S.;
Cutler, David L.

Publication type:

Article

Noradrenaline inhibits autonomous activity in the isolated guinea pig bladder.

Published in:

BJU International, 2004, v. 93, n. 3, p. 401, doi. 10.1111/j.1464-410X.2003.04626.x

By:

Gillespie, J. I.

Publication type:

Article

Chromium and formoterol therapy for obesity-induced asthma in rats.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1537022

By:

Ibrahim, Rania T.;
Moustafa, Yasser M.;
Alwaili, Maha Abdullah;
Alrebdi, Amjad N.;
Alharthi, Afaf;
Noufal, Noha R.;
Khodeer, Dina M.

Publication type:

Article

Chromium and formoterol therapy for obesity-induced asthma in rats.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1537022

By:

Ibrahim, Rania T.;
Moustafa, Yasser M.;
Alwaili, Maha Abdullah;
Alrebdi, Amjad N.;
Alharthi, Afaf;
Noufal, Noha R.;
Khodeer, Dina M.

Publication type:

Article

Safety and Efficacy of 12-Week or Longer Indacaterol Treatment in Moderate-to-Severe COPD Patients: A Systematic Review.

Published in:

Lung (0341-2040), 2013, v. 191, n. 2, p. 135, doi. 10.1007/s00408-012-9444-2

By:

Jiang, Fa-Ming;
Liang, Zong-An;
Zheng, Qiao-Ling;
Wang, Rong-Chun;
Luo, Jian;
Li, Chun-Tao

Publication type:

Article

The Effect of Inhaled Budesonide and Formoterol on Bronchial Remodeling and HRCT Features in Young Asthmatics.

Published in:

Lung (0341-2040), 2007, v. 185, n. 2, p. 89, doi. 10.1007/s00408-006-0007-2

By:

Capraz, Firuz;
Kunter, Erdogan;
Cermik, Hakan;
Ilvan, Ahmet;
Pocan, Suheyl

Publication type:

Article

Synergistic effect of formoterol and mometasone in a mouse model of allergic lung inflammation.

Published in:

British Journal of Pharmacology, 2007, v. 152, n. 1, p. 83, doi. 10.1038/sj.bjp.0707381

By:

Wyss, D.;
Bonneau, O.;
Trifilieff, A.

Publication type:

Article

Systemic administration of β2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.

Published in:

British Journal of Pharmacology, 2006, v. 147, n. 6, p. 587, doi. 10.1038/sj.bjp.0706669

By:

Ryall, James G.;
Sillence, Martin N.;
Lynch, Gordon S.

Publication type:

Article

Positive interaction of theß2-agonist CHF 4226.01 with budesonide in the control of bronchoconstriction induced by acetaldehyde in the guinea-pigs.

Published in:

2005

By:

Rossoni, Giuseppe;
Manfredi, Barbara;
Razzetti, Roberta;
Civelli, Maurizio;
Bongrani, Stefano;
Berti, Ferruccio

Publication type:

Abstract

Desensitisation of mast cell ß2-adrenoceptor-mediated responses by salmeterol and formoterol.

Published in:

British Journal of Pharmacology, 2004, v. 141, n. 1, p. 163, doi. 10.1038/sj.bjp.0705599

By:

Scola, Anne-Marie;
Chong, Lee K.;
Suvarna, S. Kim;
Chess-Williams, Russell;
Peachell, Peter T.

Publication type:

Article

Normalisation of airflow limitation in asthma: Post‐hoc analyses of TRIMARAN and TRIGGER.

Published in:

Clinical & Translational Allergy, 2022, v. 12, n. 4, p. 1, doi. 10.1002/clt2.12145

By:

Papi, Alberto;
Singh, Dave;
Virchow, J. Christian;
Canonica, G. Walter;
Vele, Andrea;
Georges, George

Publication type:

Article

Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies.

Published in:

Drug Safety, 2021, v. 44, n. 4, p. 467, doi. 10.1007/s40264-020-01041-z

By:

FitzGerald, J. Mark;
O'Byrne, Paul M.;
Bateman, Eric D.;
Barnes, Peter J.;
Zheng, Jinping;
Ivanov, Stefan;
Lamarca, Rosa;
Larsdotter, Ulrika;
Emerath, Ulrika;
Jansen, Gerreke;
Puu, Margareta;
Alagappan, Vijay K. T.;
Surmont, Filip;
Reddel, Helen K.

Publication type:

Article

A Benefit-Risk Assessment of Inhaled Long-Acting β2-Agonists in the Management of Obstructive Pulmonary Disease.

Published in:

Drug Safety, 2004, v. 27, n. 10, p. 689, doi. 10.2165/00002018-200427100-00001

By:

Sovani, Milind P;
Whale, Christopher I.;
Tattersfield, Anne. E

Publication type:

Article

A post-marketing surveillance study of formoterol (Foradil): its use in general practice in England.

Published in:

2002

By:

Wilton, Lynda V.;
Shakir, Saad A.

Publication type:

journal article

Cost-effectiveness analysis of three different combinations of inhalers for severe and very severe chronic obstructive pulmonary disease patients at a tertiary care teaching hospital of South India.

Published in:

Perspectives in Clinical Research, 2015, v. 6, n. 3, p. 150, doi. 10.4103/2229-3485.159940

By:

Altaf, Mohammed;
Zubedi, Ayesha Mubeen;
Nazneen, Fareesa;
Kareemulla, Shaik;
Amir Ali, Syed;
Aleemuddin, N. M.;
Hannan Hazari, Md. Abdul

Publication type:

Article

Effect of vitamin D3 on mild to moderate persistent asthmatic patients: A randomized controlled pilot study.

Published in:

Perspectives in Clinical Research, 2014, v. 5, n. 4, p. 167, doi. 10.4103/2229-3485.140556

By:

Nageswari, A. D.;
Rajanandh, M. G.;
Priyanka, R. Kamala;
Rajasekhar, P.

Publication type:

Article

A long-acting β2-adrenergic agonist increases the expression of muscarine cholinergic subtype-3 receptors by activating the β2-adrenoceptor cyclic adenosine monophosphate signaling pathway in airway smooth muscle cells.

Published in:

Molecular Medicine Reports, 2015, v. 11, n. 6, p. 4121, doi. 10.3892/mmr.2015.3307

By:

YUAN-HUA LIU;
SONG-ZE WU;
GANG WANG;
NI-WEN HUANG;
CHUN-TAO LIU

Publication type:

Article

Adjustable maintenance dosing: suitability of budesonide/formoterol in a single inhaler and overview of a clinical study programme.

Published in:

International Journal of Clinical Practice (Supplement), 2004, v. 58, p. 9, doi. 10.1111/j.1368-504X.2004.00260.x

By:

Canonica, G.W.;
Vignola, A.M.

Publication type:

Article

Adjustable maintenance dosing with budesonide/formoterol in a single inhaler– efficacy and safety.

Published in:

International Journal of Clinical Practice (Supplement), 2004, v. 58, p. 18, doi. 10.1111/j.1368-504X.2004.00261.x

By:

Fitzgerald, J.M.;
Olsson, P.;
Michils, A.

Publication type:

Article

Adjustable maintenance dosing with budesonide/formoterol (Symbicort®) reduces treatment costs in asthma.

Published in:

International Journal of Clinical Practice (Supplement), 2004, v. 58, p. 33, doi. 10.1111/j.1368-504X.2004.00263.x

By:

Ind, P.W.;
Ställberg, B.;
Willich, S.N.

Publication type:

Article

The application of budesonide/formoterol (Symbicort®) adjustable maintenance dosing to real-life clinical practice.

Published in:

International Journal of Clinical Practice (Supplement), 2004, v. 58, p. 42, doi. 10.1111/j.1368-504X.2004.00264.x

By:

Haughney, J.;
Sears, M.R.

Publication type:

Article

Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β2-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler.

Published in:

Journal of Asthma, 2010, v. 47, n. 4, p. 447, doi. 10.3109/02770901003725684

By:

Berger, William E.;
Noonan, Michael J.

Publication type:

Article

Budesonide/formoterol Combination as a Maintenance and Rescue Therapy.

Published in:

Journal of Asthma, 2009, v. 46, n. 7, p. 647, doi. 10.1080/02770900902929491

By:

Su, Kang-Cheng;
Tsai, Cheng-Chien;
Kuo, Lu-Cheng;
Kuo, Sow-Hsong;
Perng, Diahn-Warng

Publication type:

Article

Early Bronchodilatory Effects of Budesonide/Formoterol pMDI Compared with Fluticasone/Salmeterol DPI and Albuterol pMDI: 2 Randomized Controlled Trials in Adults with Persistent Asthma Previously Treated with Inhaled Corticosteroids.

Published in:

Journal of Asthma, 2008, v. 45, n. 4, p. 265, doi. 10.1080/02770900801890505

By:

Hampel, Frank C.;
Martin, Paula;
Mezzanotte, William S.

Publication type:

Article

Effect of Budesonide and Formoterol on Il-6 and Il-8 Release from Primary Bronchial Epithelial Cells.

Published in:

Journal of Asthma, 2008, v. 45, n. 3, p. 201, doi. 10.1080/02770900801890372

By:

Strandberg, Karin;
Palmberg, Lena;
Larsson, Kjell

Publication type:

Article

Abstract.

Published in:

2006

By:

Randolph, Christopher

Publication type:

Abstract

Combination Inhalers Containing Inhaled Corticosteroids and Long-Acting β 2 -Agonists: Improved Clinical Efficacy and Dosing Options in Patients with Asthma.

Published in:

Journal of Asthma, 2005, v. 42, n. 9, p. 715, doi. 10.1080/02770900500305748

By:

Ankerst, Jaro

Publication type:

Article

Efficacy and Safety of Formoterol Delivered Via a New Multidose Dry Powder Inhaler (Certihaler™) in Adolescents and Adults with Persistent Asthma.

Published in:

Journal of Asthma, 2005, v. 42, n. 2, p. 101, doi. 10.1081/JAS-200051334

By:

LaForce, C.;
Prenner, B.M.;
Andriano, K.;
Lavecchia, C.;
Yegen, Ümit

Publication type:

Article

Formoterol Delivered via the Dry Powder Aerolizer® Inhaler Versus Albuterol MDI and Placebo in Mild-to-Moderate Asthma: A Randomized, Double-Blind, Double-Dummy Trial.

Published in:

Journal of Asthma, 2003, v. 40, n. 5, p. 505, doi. 10.1081/JAS-120018780

By:

Pleskow, W.;
LaForce, C. F.;
Yegen, Ü.;
Matos, D.;
Della Cioppa, G.

Publication type:

Article

Impaired Bronchoprotection Is Not Induced by Increased Smooth Muscle Mass in Chronic Treatment In Vivo with Formoterol in Asthmatic Mouse Model.

Published in:

West Indian Medical Journal, 2014, v. 63, n. 6, p. 641, doi. 10.7727/wimjopen.2014.177

By:

Luo, W.;
Liu, C-T;
Yang, Q-H;
Yu, Q.;
Wang, T.

Publication type:

Article

Soluble Guanylate Cyclase Agonists Induce Bronchodilation in Human Small Airways.

Published in:

American Journal of Respiratory Cell & Molecular Biology, 2020, v. 62, n. 1, p. 43, doi. 10.1165/rcmb.2019-0001OC

By:

Koziol-White, Cynthia J.;
Ghosh, Arnab;
Sandner, Peter;
Erzurum, Serpil E.;
Stuehr, Dennis J.;
Panettieri Jr., Reynold A.

Publication type:

Article

Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy.

Published in:

Supportive Care in Cancer, 2014, v. 22, n. 5, p. 1269, doi. 10.1007/s00520-013-2081-3

By:

Greig, C.;
Johns, N.;
Gray, C.;
MacDonald, A.;
Stephens, N.;
Skipworth, R.;
Fallon, M.;
Wall, L.;
Fox, G.;
Fearon, K.

Publication type:

Article

Concomitant occasional use of salbutamol influences bronchoprotective responsiveness afforded by formoterol in patients with the glycine-16 genotype.

Published in:

European Journal of Clinical Pharmacology, 2004, v. 59, n. 11, p. 791, doi. 10.1007/s00228-003-0703-2

By:

Sims, Erika J.;
Lipworth, Brian J.

Publication type:

Article

Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics.

Published in:

European Journal of Clinical Pharmacology, 2000, v. 56, n. 5, p. 363, doi. 10.1007/s002280000160

By:

Rosenborg, J.;
Bengtsson, T.;
Larsson, P.;
Blomgren, A.;
Persson, G.;
Lö;tvall, J.

Publication type:

Article

AstraZeneca's Triple Inhaled Therapy Meets Primary Endpoints in Phase 3 Trials of Uncontrolled Asthma.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article